$Plus Ther_老虎社区_美港股上老虎

zeroxu666
06-26

$Plus Therapeutics, Inc.(PSTV)$ 今天宣布，美国食品药品监督管理局（FDA）已批准其REYOBIQ™ （铼Re186 Obisbemeda）的新药临床试验申请（编号：168178），用于治疗患有幕上复发性、难治性或进展性高级别胶质瘤（HGG）和室管膜瘤的儿科患者。该试验将被称为ReSPECT-PBC试验，由美国国防部提供的300万美元研究经费资助

免责声明：上述内容仅代表发帖人个人观点，不构成本平台的任何投资建议。

推荐
最新

暂无评论

热议股票

{"i18n":{"language":"zh_CN"},"data":{"magic":2,"id":450093671772384,"tweetId":"450093671772384","gmtCreate":1750912826915,"gmtModify":1750912828270,"author":{"id":3544572238091832,"idStr":"3544572238091832","authorId":3544572238091832,"authorIdStr":"3544572238091832","name":"zeroxu666","avatar":"https://static.laohu8.com/default-avatar.jpg","vip":1,"userType":1,"introduction":"","boolIsFan":false,"boolIsHead":false,"crmLevel":5,"crmLevelSwitch":0,"currentWearingBadge":{"badgeId":"35ec162348d5460f88c959321e554969-3","templateUuid":"35ec162348d5460f88c959321e554969","name":"传说交易员","description":"证券或期货账户累计交易次数达到300次","bigImgUrl":"https://static.tigerbbs.com/656db16598a0b8f21429e10d6c1cb033","smallImgUrl":"https://static.tigerbbs.com/03f10910d4dd9234f9b5702a3342193a","grayImgUrl":"https://static.tigerbbs.com/0c767e35268feb729d50d3fa9a386c5a","redirectLinkEnabled":0,"hasAllocated":1,"isWearing":1,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.21","exceedPercentage":"93.16%","individualDisplayEnabled":0},"individualDisplayBadges":[],"fanSize":48,"starInvestorFlag":false},"themes":[],"images":[],"coverImages":[],"html":"<html><head></head><body><p><a href=\"https://laohu8.com/S/PSTV\">$Plus Therapeutics, Inc.(PSTV)$</a> 今天宣布，美国食品药品监督管理局（FDA）已批准其REYOBIQ™ （铼Re186 Obisbemeda）的新药临床试验申请（编号：168178），用于治疗患有幕上复发性、难治性或进展性高级别胶质瘤（HGG）和室管膜瘤的儿科患者。该试验将被称为ReSPECT-PBC试验，由美国国防部提供的300万美元研究经费资助</p></body></html>","htmlText":"<html><head></head><body><p><a href=\"https://laohu8.com/S/PSTV\">$Plus Therapeutics, Inc.(PSTV)$</a> 今天宣布，美国食品药品监督管理局（FDA）已批准其REYOBIQ™ （铼Re186 Obisbemeda）的新药临床试验申请（编号：168178），用于治疗患有幕上复发性、难治性或进展性高级别胶质瘤（HGG）和室管膜瘤的儿科患者。该试验将被称为ReSPECT-PBC试验，由美国国防部提供的300万美元研究经费资助</p></body></html>","text":"$Plus Therapeutics, Inc.(PSTV)$ 今天宣布，美国食品药品监督管理局（FDA）已批准其REYOBIQ™ （铼Re186 Obisbemeda）的新药临床试验申请（编号：168178），用于治疗患有幕上复发性、难治性或进展性高级别胶质瘤（HGG）和室管膜瘤的儿科患者。该试验将被称为ReSPECT-PBC试验，由美国国防部提供的300万美元研究经费资助","highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"link":"https://laohu8.com/post/450093671772384","repostId":0,"isVote":1,"tweetType":1,"viewCount":367,"commentLimit":10,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"symbols":["PSTV"],"verified":2,"subType":0,"readableState":1,"langContent":"CN","currentLanguage":"CN","warmUpFlag":false,"orderFlag":false,"shareable":true,"causeOfNotShareable":"","featuresForAnalytics":[],"commentAndTweetFlag":false,"andRepostAutoSelectedFlag":false,"upFlag":false,"length":276,"optionInvolvedFlag":false,"xxTargetLangEnum":"ZH_CN"},"commentList":[],"hasMoreComment":false,"orderType":2}